SNAP · SnAP Reagents for Accelerating Drug Discovery

A new class of reagents for directly accessing more drug like molecules at the early stages of drug development will be developed. This technology is based on a new method to easily prepare saturated N-heterocycles, which have proven advantages in drug like molecules but are difficult to prepare at the early stages of lead discovery and optimization. The key reactions and reagent has been validated and partners for distribution and test marketing established. The ERC PoC funding will support a first delivery of the reagents and support the development of new reagent classes in consultation with key industry leaders.